Peer review is the primary quality control system for scientific research. Before a study gets published in a reputable journal, other experts in the same field read it carefully, check the methods, evaluate the conclusions, and flag errors. This process shapes what enters the scientific record and, by extension, what informs medical treatments, public policy, and everyday decisions about health and safety.
How Peer Review Actually Works
When a researcher submits a paper to a journal, the editor sends it to two or more independent experts for evaluation. These reviewers scrutinize the experimental design, the appropriateness of the methods, the validity of the data, and whether the conclusions follow logically from the results. They then recommend that the editor accept the paper, reject it, or send it back to the authors with requests for revisions.
This process serves two distinct functions. First, it filters out work that doesn’t meet standards for validity, significance, or originality, preventing unwarranted claims and unsupported interpretations from reaching the broader scientific community. Second, it improves manuscripts that do have merit. Reviewers routinely catch statistical errors, suggest additional analyses, identify gaps in reasoning, and push authors to clarify their writing. Many published papers are substantially better than the version originally submitted, specifically because of reviewer feedback.
Protecting the Integrity of Science
The stakes of publishing flawed research are real. More than 10,000 scientific papers were retracted in 2023 alone, and the reasons behind retractions have shifted over time. Traditional forms of misconduct like data fabrication, falsification, and plagiarism are now joined by large-scale organized fraud, including paper mills that produce fake studies for profit and schemes involving fabricated peer reviews. Clinical and life sciences account for roughly half of misconduct-related retractions, while engineering and computer science fields have even higher retraction rates per published paper, driven largely by these orchestrated fraudulent practices.
Peer review can’t catch every instance of fraud, but it remains the first and most widely used line of defense. Reviewers who know a field deeply can spot implausible results, recognize recycled data, and identify methodological shortcuts that automated checks would miss. The system also creates accountability: knowing that experts will evaluate your work discourages sloppy science and encourages researchers to hold themselves to higher standards before they ever hit “submit.”
Bias in the Review Process
Peer review isn’t perfect, and one of its most studied weaknesses is bias. In the most common model, called single-blind review, the reviewers know who wrote the paper but the authors don’t know who reviewed it. Research published in JAMA found that when prestigious authors’ names and institutions were visible to reviewers, 87% recommended acceptance. When those same papers were evaluated with author information hidden (double-blind review), the acceptance rate dropped to 68%. Reviewers also gave higher ratings for methodology when they could see a well-known name attached to the work.
This finding highlights a real tension. Reputation can unconsciously influence how reviewers judge the science itself. Double-blind review reduces this effect but isn’t universally adopted, partly because in small fields, reviewers can often guess who wrote a paper based on the topic and citations. A newer model, open peer review, makes everything transparent: authors know who reviewed their paper, and in some cases the reviews are published alongside the article. Each approach trades off different risks, from prestige bias to potential retaliation.
The Time Cost of Getting It Right
Thorough review takes time, and that’s one of the most common frustrations researchers face. Across health policy journals, the median time from submission to a first peer-reviewed decision is about 60 days, but reaching a final decision after revisions takes a median of 198 days. The entire process from submission to online publication averages around 196 days, with some papers taking nearly a year. Highly selective journals tend to move faster on initial decisions (a median of 3 days to desk-reject papers versus 13 days at less selective journals), because they filter more aggressively before sending work out for review.
These timelines matter, especially during health emergencies when new findings need to reach clinicians quickly. But rushing the process creates its own dangers. During the early months of the COVID-19 pandemic, several high-profile papers were retracted after expedited reviews failed to catch serious problems. Speed and rigor exist in constant tension.
Why Reviewers Do Unpaid Work
One of the more surprising aspects of peer review is that most reviewers aren’t paid. Journals generate revenue through subscriptions or publication fees, but the experts doing the actual evaluating typically volunteer their time. This creates a persistent problem: as the volume of submitted papers grows, the pool of willing, qualified reviewers hasn’t kept pace.
Some journals have started experimenting with compensation. Biology Open offers freelance reviewers $300 per manuscript. The ResearchHub Journal pays referees in cryptocurrency. PeerJ provides tokens redeemable against future publication fees. Other incentive models include continuing education credits, ORCID accreditation (a verified record of review activity), conference fee discounts, and consideration for editorial board positions. Some researchers have proposed that peer review activity should count toward tenure and promotion decisions, treating it as the essential professional contribution it is rather than an invisible favor. One proposal suggests a flat fee of around $200 per review, or $450 for papers at for-profit publishers, to formalize reviewing as a compensated professional service.
How Peer Review Shapes Policy
Peer-reviewed research doesn’t just stay in academic journals. It forms the evidence base for government health guidelines, drug approvals, environmental regulations, and public health interventions. When policymakers evaluate whether a treatment works or whether a chemical is safe, the quality of the underlying evidence matters enormously, and the peer review process is what separates vetted findings from preliminary claims.
That said, the relationship between evidence and policy is messier than a simple pipeline from lab to legislation. Policymakers often filter scientific evidence through political priorities, public sentiment, and practical constraints. Researchers who want their peer-reviewed work to actually influence decisions need to translate complex findings into accessible language and engage with the policy process directly. The peer review stamp doesn’t guarantee that evidence will be used, but it does guarantee that the evidence has been evaluated by people qualified to judge it.
The Role of AI in Review
Artificial intelligence is starting to enter the peer review process, but with significant guardrails. Some journals use AI tools to screen for plagiarism, check statistical reporting, or flag formatting issues. The potential to speed up routine checks is real, but core functions like evaluating whether a study’s conclusions are novel, assessing figure accuracy, or judging clinical importance remain difficult to automate.
Major journals have adopted strict policies around AI use in review. The JAMA Network prohibits reviewers from uploading confidential manuscripts to AI tools, because doing so could expose unpublished data to systems that use uploaded content for training. Reviewers who do use AI as a resource during their evaluation must disclose it. The International Committee of Medical Journal Editors has stated that AI cannot serve as an author because it cannot be held accountable for the accuracy or integrity of the work. AI-generated text can sound authoritative while being incorrect, incomplete, or biased, which is precisely the kind of problem peer review exists to catch. For now, the consensus is that AI should assist human reviewers, not replace them, with editors retaining full accountability for the rigor of what gets published.
Ethical Expectations for Reviewers
The Committee on Publication Ethics (COPE) sets widely adopted ethical standards for the review process. Reviewers must keep manuscripts confidential and cannot share content or use unpublished ideas for their own benefit. They must declare any competing interests, whether financial, personal, or professional. A reviewer who works at the same institution as an author, or who has been a recent collaborator, mentor, or grant partner within the past three years, should decline the assignment.
Reviewers also shouldn’t accept a manuscript just to get an early look at a competitor’s work, or review a paper closely related to something they have under consideration elsewhere. These rules exist because the system runs on trust. Researchers share their unpublished work with strangers, and those strangers are expected to evaluate it fairly without exploiting the access they’ve been given. When that trust breaks down, the entire foundation of scientific publishing weakens.